Avedro Announces 500th Cross-linking Device Sale Outside the US
WALTHAM, Mass.--(BUSINESS WIRE)--Avedro announces that it has sold its 500th cross-linking device outside of the United States. Study data presented on its non-surgical PiXL procedure shows promise for low myopia correction.
